Richter Seeks Acquisitions in Women’s Health, CEO Orban Says

Gedeon Richter, Hungary’s biggest drugmaker, is looking to boost its women’s health-care portfolio via acquisitions as its top medicine ages.

The company is looking for innovative products in fertility, endometriosis, contraception and hormonal therapy, among others. Targets could be outside Europe to fulfill “global ambitions,” Chief Executive Officer Gabor Orban told Bloomberg News in an interview.

Orban, who’s no relation to Hungarian Prime Minister Viktor Orban, aims to double Richter’s women’s health-care revenue and significantly improving its profit contribution over the next decade.

“We’re continuously looking to expand our portfolio, especially in women’s health-care,” Orban said Wednesday. He ...